Shalin J. Shah
Department of Radiation Oncology, Division of Radiation Oncology
Present Title & Affiliation
Primary Appointment
Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Section Chief - Houston Area Locations, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Sugar Land, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Dr. Shah is actively working to improve access to clinical trials for patients in the community. He is doing this from the ground up, working with both researchers and administrators to improve the clinical trial infrastructure available at the Houston Area Locations.
ACTIVE TRIALS
Research Trial – A Randomized Comparision of a Plant Based Tube Feed (Liquid Hope) versus Standard of Care Tube Feeds for Head and Neck Cancer Patients. 2019-present
Clinical Interests
As a radiation oncologist charged with the mission of helping patients fight cancer, I specialize in treating all types of cancers, with a focus on Head and Neck as well as Prostate Cancers. I am actively involved in expanding the access to Proton Therapy for patients in the Houston Area Locations.
Education & Training
Degree-Granting Education
| 2002 | Albert Einstein College of Medicine, Bronx, New York, US, MD |
| 1997 | Cornell University, College of Agriculture and Life Sciences, Ithaca, New York, US, BS in Biometry and Statistics-with Distinction |
Postgraduate Training
| 2012-2012 | Ayurveda Training Course for Health Professionals-Level I, Maharishi Ayurveda Association of America, La Jolla, California |
| 2009-2011 | Lifestyle Counselor, Ayurvedic Medicine, American Institute of Vedic Studies, Santa Fe, New Mexico |
| 2007-2008 | Clinical Research Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2002-2007 | Clinical Residency, Albert Einstein College of Medicine/Montefiore Hospital, Bronx, New York |
| 2002-2003 | Clinical Rotations, Albert Einstein College of Medicine/Montefiore Hospital, Bronx, New York |
| 2001-2002 | Research Fellowship, Albert Einstein College of Medicine, Bronx, New York |
Board Certifications
| 2017 | American Board of Medical Quality |
| 2008 | American Board of Radiology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014
Administrative Appointments/Responsibilities
Clinical Section Chief - Houston Area Locations, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Sugar Land, TX, 2019 - Present
Center Medical Director, MD Anderson Cancer Center - Sugar Land Regional Care Center, Sugar Land, TX, 2011 - 2014
Other Appointments/Responsibilities
Advisory Board, Blue Cure Foundation, Houston, TX, 2013 - Present
Executive Board, Indo American Cancer Awareness Network, Houston, TX, 2012 - Present
Executive Board Member, Fort Bend Medical Society, Sugar Land, TX, 2012 - 2014
Research Fellowship, Albert Einstein Summer Research Fellowship, Department of Infectious Diseases, Beth Israel Hospital, New York, NY, 1998 - 1998
International Clinical Oncology Fellowship, M.P. Shah Cancer Hospital, Amdavad, 1995 - 1995
Institutional Committee Activities
Member, Radiation Oncology Clinical Research Council, 2017 - Present
Member, HAL Executive Research Committee, 2017 - Present
Committee Member, Electronic Medical Record (Epic) Working Group, 2015 - Present
Leader, Patient Delays Project Workgroup, 2014 - 2014
Board Member, Physicians Relations Advisory Board, 2011 - Present
Honors & Awards
| 2019 | Luis Delclos Excellence in Teaching Award - 2019, MD Anderson Cancer Center |
| 2009 | America's Top Oncologists, Consumer Research Council of America |
| 2008 | Patient's Choice Award, Vitals.com |
| 2006 | Chief Resident, The University of Texas M.D. Anderson Cancer Center - Department of Radiation Oncology |
| 2005 | ASCO International Mentorship Award, ASCO |
| 2003 | Community Service Award, BJ Medical Alumni Association |
| 2002 | Distinction for Research in Radiation Oncology, Albert Einstein College of Medicine |
| 2001 | Albert Einstein Research Fellowship, Albert Einstein College of Medicine |
| 1998 | Albert Einstein Summer Research Award, Albert Einstein College of Medicine |
| 1997 | Dean's Award for Academic Excellence, College of Agriculture and Life Sciences |
| 1997 | Golden Key National Honor Society, Golden Key National Honor Society |
| 1997 | Graduation with Distinction, Cornell University |
| 1994 | International Clinical Oncology Fellowship, Gujarat Cancer Society |
| 1993 | Dean's list for the College of Agriculture and Life Sciences, Cornell University |
| 1993 | Faculty Award for Excellence in Biology, Irvington High School |
| 1993 | Texaco Star Academic Challenge Scholarship, Texaco Corporation |
| 1992 | Dartmouth Book Award, Dartmouth Alumni Association |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial. Int J Radiat Oncol Biol Phys 121(4):885-893, 2025. e-Pub 2025. PMID: 39486645.
- Mohamad, O, Kouzi, ZE, Kouzy, R, Choi, S, Mok, H, Hoffman, K, Nguyen, Q, Hassanzadeh, CJ, Tang, C, Park, RJ, Shah, SJ, McGuire, SE, Mayo, LL, Kim, Y, Prajapati, S, Vijayan, S, Kudchadker, RJ, Bruno, TL, Frank, SJ. Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer. Brachytherapy 24(2):1-9, 2025. e-Pub 2025.
- Carriere, P, Alhalabi, O, Gao, J, Mohamad, O, Campbell, M, Shah, AY, Goswami, S, Bree, KK, Lee, B, Navai, N, Mok, H, Mayo, LL, Guo, CC, Nguyen, Q, McGuire, SE, Park, R, Shah, SJ, Hoffman, K, Frank, SJ, Tang, C, Choi, S, Kamat, A, Hassanzadeh, CJ. Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer. Clinical and Translational Radiation Oncology 49, 2024. e-Pub 2024.
- Chung CV, Khan MS, Olanrewaju A, Pham M, Nguyen QT, Patel T, Das P, O'Reilly MS, Reed VK, Jhingran A, Simonds H, Ludmir EB, Hoffman KE, Naidoo K, Parkes J, Aggarwal A, Mayo LL, Shah SJ, Tang C, Beadle BM, Wetter J, Walker G, Hughes S, Mullassery V, Skett S, Thomas C, Zhang L, Nguyen S, Mumme RP, Douglas RJ, Baroudi H, Court LE. Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites. Radiother Oncol 202:110609, 2024. e-Pub 2024. PMID: 39486482.
- Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Koay, EJ. Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy. Oral Oncology 157, 2024. e-Pub 2024. PMID: 39024700.
- Sosa, A, Rooney, MK, Thames, HD, Sanders, JW, Swanson, DM, Choi, S, Nguyen, Q, Mok, H, Kuban, DA, Ron Zhu, X, Shah, SJ, Mayo, LL, Hoffman, K, Tang, C, McGuire, SE, Sahoo, N, Zhang, X, Lee, AK, Pugh, T, Mahmood, U, Davis, JW, Chapin, BF, Corn, P, Kudchadker, R, Ausat, N, Frank, SJ. Proton therapy toxicity outcomes for localized prostate cancer. Clinical and Translational Radiation Oncology 48, 2024. e-Pub 2024. PMID: 39188999.
- Weng, JK, Mesko, S, Chronowski, G, Lee, PP, Choi, S, Das, P, Koong, A, French, KE, Aloia, TA, Ehlers, R, Elrod-Joplin, D, Kerr, A, Smith, R, Martinez, W, Bloom, ES, Shah, SJ, Ning, M, Liao, Z, Herman, JM, Moningi, S, Moreno, AC, Nguyen, Q. Optimizing Outpatient Radiation Oncology Consult Workflow by Using Time-Driven Activity-Based Costing. JCO Oncology Practice 20(5):732-738, 2024. e-Pub 2024. PMID: 38330252.
- Wang, L, Sanders, JW, Ward, JF, Lee, SR, Poenisch, F, Swanson, DM, Sahoo, N, Zhu, XR, Ma, J, Kudchadker, RJ, Choi, S, Nguyen, Q, Mayo, LL, Shah, SJ, Frank, SJ. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy. Cancers 16(3), 2024. e-Pub 2024. PMID: 38339376.
- Garg, AK, Hernandez, M, Schlembach, PJ, Bowers, JR, McAleer, MF, Brown, P, Gopal, R, Wiederhold, LR, Swanson, T, Shah, SJ, Li, J, Ferguson, SD, Philip, NV, Degracia, L, Bloom, ES, Chun, SG. A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases. JNCI Cancer Spectrum 7(6), 2023. e-Pub 2023. PMID: 37944053.
- Sosa, A, Thames, HD, Sanders, JW, Choi, S, Nguyen, Q, Mok, H, Zhu, XR, Shah, SJ, Mayo, LL, Hoffman, K, Tang, C, Lee, AK, Pugh, T, Kudchadker, R, Frank, SJ. Proton therapy for the management of localized prostate cancer. Radiotherapy and Oncology 188, 2023. e-Pub 2023. PMID: 37597805.
- Contrera, KJ, Tam, S, Pytynia, KB, Diaz Jr, EM, Hessel, AC, Goepfert, RP, Lango, MN, Su, SY, Myers, JN, Weber, RS, Eguia, A, Pisters, PW, Adair, DK, Nair, AS, Rosenthal, D, Mayo, LL, Chronowski, G, Zafereo, M, Shah, SJ. Impact of Cancer Care Regionalization on Patient Volume. Annals of surgical oncology 30(4):2331-2338, 2023. e-Pub 2023. PMID: 36581726.
- Contrera, KJ, Tam, S, Pytynia, KB, Diaz Jr, EM, Hessel, AC, Goepfert, RP, Lango, MN, Su, SY, Myers, JN, Weber, RS, Eguia, A, Pisters, PW, Adair, DK, Nair, AS, Rosenthal, D, Mayo, LL, Chronowski, G, Zafereo, M, Shah, SJ. ASO Visual Abstract. Annals of surgical oncology 30(4):2341-2342, 2023. e-Pub 2023. PMID: 36720835.
- Ng, SP, Cardenas, CE, Bahig, H, Elgohari, B, Wang, J, Johnson, JM, Moreno, AC, Shah, SJ, Garden, AS, Phan, J, Gunn, GB, Frank, SJ, Ding, Y, Na, L, Yuan, Y, Urbauer, D, Mohamed, AS, Rosenthal, D, Morrison, WH, MacManus, M, Fuller, C. Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer. Current Oncology 29(9):6303-6313, 2022. e-Pub 2022. PMID: 36135064.
- Diao, K, Nguyen, TP, Moreno, AC, Reddy, JP, Garden, AS, Wang, C, Tung, S, Wang, C, Wang, XA, Rosenthal, D, Fuller, C, Gunn, GB, Frank, SJ, Morrison, WH, Shah, SJ, Lee, A, Spiotto, MT, Su, SY, Ferrarotto, R, Phan, J. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival. Head and Neck 43(11):3331-3344, 2021. e-Pub 2021. PMID: 34269492.
- Weng, JK, Lei, X, Schlembach, PJ, Bloom, ES, Shaitelman, SF, Arzu, I, Chronowski, G, Dvorak, T, Grade, E, Hoffman, K, Perkins, GH, Reed, VK, Shah, SJ, Stauder, MC, Strom, EA, Tereffe, W, Woodward, W, Hortobagyi, GN, Hunt, KK, Buchholz, TA, Smith, B. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. International Journal of Radiation Oncology Biology Physics 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
- Patel, RR, He, K, Barsoumian, H, Chang, JY, Tang, C, Verma, V, Comeaux, N, Chun, SG, Gandhi, S, Truong, M, Erasmus, JJ, Hong, DS, Lee, PP, Ning, M, Nguyen, Q, Heymach, JV, Altan, M, Blumenschein, GR, Fossella, FV, Sezen, D, Chen, D, Carter, B, Davies, MA, Glitza, IC, Diab, A, Ferrarotto, R, Cabanillas, ME, Yuan, Y, Shah, SJ, Parra Cuentas, ER, Sun, B, Cortez, MA, Welsh, J. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy. Radiotherapy and Oncology 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
- Hanania, A, Zhang, X, Gunn, GB, Rosenthal, D, Garden, AS, Fuller, C, Phan, J, Reddy, JP, Moreno, AC, Chronowski, G, Shah, SJ, Ausat, N, Hanna, EY, Ferrarotto, R, Frank, SJ. Proton therapy for major salivary gland cancer. International Journal of Particle Therapy 8(1):261-272, 2021. e-Pub 2021. PMID: 34285952.
- Smith, GL, Fu, S, Ning, M, Nguyen, DK, Busse, PM, Foote, RL, Garden, AS, Gunn, GB, Fuller, C, Morrison, WH, Chronowski, G, Shah, SJ, Mayo, LL, Phan, J, Reddy, JP, Snider, JW, Patel, SH, Katz, SR, Lin, A, Mohammed, N, Dagan, R, Lee, N, Rosenthal, D, Frank, SJ. Work outcomes after intensity- modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for oropharyngeal cancer. International Journal of Particle Therapy 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
- Gunn, GB, Garden, AS, Ye, R, Ausat, N, Dahlstrom, KR, Morrison, WH, Fuller, C, Phan, J, Reddy, JP, Shah, SJ, Mayo, LL, Chun, SG, Chronowski, G, Moreno, AC, Myers, JN, Hanna, EY, Esmaeli, B, Gillison, M, Ferrarotto, R, Hutcheson, KA, Chambers, MS, Ginsberg, LE, El-Naggar, AK, Rosenthal, D, Zhu, XR, Frank, SJ. Proton therapy for head and neck cancer. International Journal of Particle Therapy 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
- Christopherson, KM, Moreno, AC, Elgohari, B, Gross, N, Ferrarotto, R, Mohamed, AS, Gunn, GB, Goepfert, RP, Mott, FE, Shah, SJ, Fuller, C, Reddy, JP, Frank, SJ, Morrison, WH, Phan, J, Rosenthal, D, Garden, AS. Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation. Oral Oncology 113, 2021. e-Pub 2021. PMID: 33360375.
- Ng, SP, Wang, H, Pollard, C, Nguyen, TP, Bahig, H, Fuller, C, Gunn, GB, Garden, AS, Reddy, JP, Morrison, WH, Shah, SJ, Rosenthal, D, Frank, SJ, Guha-Thakurta, N, Ferrarotto, R, Hanna, EY, Su, SY, Phan, J. Patient Outcomes after Reirradiation of Small Skull Base Tumors using Stereotactic Body Radiotherapy, Intensity Modulated Radiotherapy, or Proton Therapy. Journal of Neurological Surgery, Part B: Skull Base 81(6):638-644, 2020. e-Pub 2020. PMID: 33381367.
- Grant, SR, Williamson, TD, Stieb, S, Shah, SJ, Fuller, C, Rosenthal, D, Frank, SJ, Garden, AS, Morrison, WH, Phan, J, Moreno, AC, Reddy, JP, Cardoso, R, Liu, A, Wu, R, Gunn, GB. A Dosimetric Comparison of Oral Cavity Sparing in the Unilateral Treatment of Early Stage Tonsil Cancer. Advances in Radiation Oncology 5(6):1359-1363, 2020. e-Pub 2020. PMID: 33305099.
- Bagley, AF, Garden, AS, Reddy, JP, Moreno, AC, Frank, SJ, Rosenthal, D, Morrison, WH, Gunn, GB, Fuller, C, Shah, SJ, Ferrarotto, R, Sturgis, EM, Gross, N, Phan, J. Highly conformal reirradiation in patients with prior oropharyngeal radiation. Head and Neck 42(11):3326-3335, 2020. e-Pub 2020. PMID: 32776401.
- Noticewala, SS, Koong, A, Bloom, ES, Choi, S, Chronowski, G, Ghafar, RA, Guadagnolo, BA, Gunn, GB, Klopp, AH, Lee, PP, Li, J, Liao, Z, Ludmir, EB, McAleer, MF, Nguyen, Q, Ning, M, Robinson, IJ, Rosenthal, D, Shah, SJ, Woodward, W, Zaebst, DJ, Dabaja, BS, Das, P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic. Advances in Radiation Oncology 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
- Ning, M, Dean, MK, Taylor, KA, Arzu, I, Fleming, N, Mutyala, N, Suresh, P, Lewis, MA, Tu, J, Hassid, VJ, Joe, T, Byler, C, Bloom, ES, Shah, SJ. Evaluation and Improvement of Bottlenecking in a Multidisciplinary Oncology Clinic. Cureus 11(5):e4583, 2019. e-Pub 2019. PMID: 31309008.
- Moreno, AC, Wilke, C, Wang, H, Tung, S, Pollard, C, Garden, AS, Morrison, WH, Rosenthal, D, Fuller, C, Gunn, GB, Reddy, JP, Shah, SJ, Frank, SJ, Takiar, V, Phan, J. Optimizing laryngeal sparing with intensity modulated radiotherapy or volumetric modulated arc therapy for unilateral tonsil cancer. Physics and Imaging in Radiation Oncology 10:29-34, 2019. e-Pub 2019. PMID: 33458265.
- Bloom, BC, Augustyn, A, Pezzi, T, Menon, H, Mayo, LL, Shah, SJ, Schwartz, DL, Chmura, SJ, Johnson, FM, Welsh, J, Chun, SG. Rescue of immunotherapy-refractory metastatic Merkel cell carcinoma with conventionally fractionated radiotherapy and concurrent pembrolizumab. Frontiers in Oncology 9(APR), 2019. e-Pub 2019. PMID: 31024834.
- Shaitelman, SF, Lei, X, Thompson, A, Schlembach, PJ, Bloom, ES, Arzu, I, Buchholz, DJ, Chronowski, G, Dvorak, T, Grade, E, Hoffman, K, Perkins, GH, Reed, VK, Shah, SJ, Stauder, MC, Strom, EA, Tereffe, W, Woodward, W, Amaya, D, Shen, Y, Hortobagyi, GN, Hunt, KK, Buchholz, TA, Smith, B. Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation. Journal of Clinical Oncology 36(35):3495-3503, 2018. e-Pub 2018. PMID: 30379626.
- Shah, SJ, Holzwanger, E, Khwaja, R, Fang, D, Figueroa-Bodine, J, Iannuzzi, C, Shi, C. A Single-Site Retrospective, Nonrandomized Study of Accelerated Partial Breast Irradiation Brachytherapy for Early-Stage Breast Cancer Treatment to Evaluate Local Tumor Control, Cosmetic Outcome, and Toxicities. Technology in Cancer Research and Treatment 15(5):645-650, 2016. e-Pub 2016. PMID: 26206768.
- Edson, MA, Garden, AS, Takiar, V, Glisson, BS, Fuller, C, Gunn, GB, Beadle, BM, Morrison, WH, Frank, SJ, Shah, SJ, Tao, R, William Jr, WN, Weber, RS, Rosenthal, D, Phan, J. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head and Neck 38:E2091-E2099, 2016. e-Pub 2016. PMID: 26920665.
- Shaitelman, SF, Schlembach, PJ, Arzu, I, Ballo, MT, Bloom, ES, Buchholz, DJ, Chronowski, G, Dvorak, T, Grade, E, Hoffman, K, Kelly, P, Ludwig, MS, Perkins, GH, Reed, VK, Shah, SJ, Stauder, MC, Strom, EA, Tereffe, W, Woodward, W, Ensor, J, Baumann, DP, Thompson, A, Amaya, D, Davis, T, Guerra, W, Hamblin, L, Hortobagyi, GN, Hunt, KK, Buchholz, TA, Smith, B. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation. JAMA Oncology 1(7):931-941, 2015. e-Pub 2015. PMID: 26247543.
- Schwartz, DL, Garden, AS, Shah, SJ, Chronowski, G, Sejpal, SV, Rosenthal, D, Chen, Y, Zhang, Y, Zhang, L, Wong, P, Garcia, JA, Ang, K, Dong, L. Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial. Radiotherapy and Oncology 106(1):80-84, 2013. e-Pub 2013. PMID: 23369744.
- Chronowski, G, Garden, AS, Morrison, WH, Frank, SJ, Schwartz, DL, Shah, SJ, Beadle, BM, Gunn, GB, Kupferman, ME, Ang, K, Rosenthal, D. Unilateral radiotherapy for the treatment of tonsil cancer. International Journal of Radiation Oncology Biology Physics 83(1):204-209, 2012. e-Pub 2012. PMID: 22019242.
- Nelson, CL, Gifford, KA, Kirsner, S, Shah, SJ, Bloom, ES, Mason, BE, Arzu, I. SU‐E‐J‐144. Medical physics 38(6):3476, 2011. e-Pub 2011.
- Yaparpalvi, R, Guha, C, Kahan, N, Minsky, L, Danish, A, Shah, SJ, Engler, M, Kalnicki, S. Comparison of Intra‐Operative Computer Optimized and Nomogram‐Based Total Implant Activities in Prostate I‐125 Seed Implants. Medical physics 32(6):1954-1955, 2005. e-Pub 2005.
- Menthena, A, Deb, N, Oertel, M, Grozdanov, PN, Sandhu, J, Shah, SJ, Guha, C, Shafritz, DA, Dabeva, MD. Bone marrow progenitors are not the source of expanding oval cells in injured liver. STEM CELLS 22(6):1049-1061, 2004. e-Pub 2004. PMID: 15536195.
- Iyengar, P, Combs, TP, Shah, SJ, Gouon-Evans, V, Pollard, JW, Albanese, C, Flanagan, L, Tenniswood, MP, Guha, C, Lisanti, MP, Pestell, RG, Scherer, PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22(41):6408-6423, 2003. e-Pub 2003. PMID: 14508521.
Other Articles
- Contrera, KJ, Tam, S, Shah, SJ, Zafereo, M ASO Author Reflections. Annals of surgical oncology 30(4):2339-2340, 2023. PMID: 36645539.
- Taku, N, Wang, L, Garden, AS, Rosenthal, D, Gunn, GB, Morrison, WH, Fuller, C, Phan, J, Reddy, JP, Moreno, AC, Spiotto, MT, Chronowski, G, Shah, SJ, Mayo, LL, Gross, N, Ferrarotto, R, Zhu, XR, Zhang, X, Frank, SJ Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck. Current treatment options in oncology 22(6), 2021. PMID: 34086150.
- Shah, SJ, Reed, VK, Arzu, I Nurse navigators in early cancer care. Breast Diseases 26(1):31-32, 2015.
- Reed, VK, Shah, SJ, Schlembach, PJ PN0(i+) breast cancer. Breast Diseases 25(2):129-130, 2014.
- Shah, SJ, Arzu, I, Reed, VK Reducing time-to-treatment in underserved latinas with breast cancer. Breast Diseases 25(3):211-212, 2014.
- Shah, SJ Beneficial effects of a combined navigator/promotora approach for hispanic women diagnosed with breast abnormalities. Breast Diseases 24(2):134, 2013.
- Guha, C, Shah, SJ, Ghosh, SS, Lee, SW, Roy-Chowdhury, N, Roy-Chowdhury, J Molecular therapies for viral hepatitis. BioDrugs 17(2):81-91, 2003. PMID: 12641487.
Letters to the Editor
- Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Lee, A, Koay, EJ. Response to recent comments on “Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy”. Oral Oncology 162, 2025.
- Ludmir, EB, Adlakha, EK, Chun, SG, Reed, VK, Arzu, I, Ahmad, N, Bloom, ES, Chronowski, G, Delclos, ME, Mayo, LL, Schlembach, PJ, Liao, Z, Koong, A, Herman, JM, Shah, SJ. Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncologica 58: 1135-1137, 2019.
Selected Presentations & Talks
Regional Presentations
- 2012. Radiation Therapy for Prostate Cancer. Conference. Radiation Therapy for Prostate Cancer, US.
National Presentations
- 2014. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irraditation: Results of a randomized trial. Conference. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irraditation: Results of a randomized trial. San Francisco, CA, US.
- 2014. The Rising Tide of Cancer in South Asians - How We Can Best Protect Ourselves. Conference. The Rising Tide of Cancer in South Asians - How We Can Best Protect Ourselves, US.
- 2013. How is Cancer Diagnosed and Treated: The Process Explained. Conference. How is Cancer Diagnosed and Treated: The Process Explained. Houston, TX, US.
- 2012. Identification of Symptom Clusters in Patients on a 'Road To Wellness Program' Undergoing Radiation Therapy for Breast Cancer. Conference. Identification of Symptom Clusters in Patients on a 'Road To Wellness Program' Undergoing Radiation Therapy for Breast Cancer. Albuquerque, NM, US.
- 2011. Mind and Body - A Holistic Approach. Conference. Mind and Body - A Holistic Approach. Houston, TX, US.
- 2011. Analysis of Intra-Fraction Chest Wall Motion During Breath Hold Treatment for Left Sided Breast Cancer. Conference. Analysis of Intra-Fraction Chest Wall Motion During Breath Hold Treatment for Left Sided Breast Cancer. Vancouver.
- 2009. Inter-fractional Movement of the Larynx and Oropharynx during Radiotherapy. Conference. Inter-fractional Movement of the Larynx and Oropharynx during Radiotherapy. Houston, TX, US.
- 2007. Whole Pelvis Radiation Therapy Followed by a PD-103 Brachytherapy Boost in Patients with Intermediate or High Risk Prostate Cancer. Conference. Whole Pelvis Radiation Therapy Followed by a PD-103 Brachytherapy Boost in Patients with Intermediate or High Risk Prostate Cancer. Chicago, IL, US.
- 2007. Feasibility of CT/MRI Compatible Cervix Sleeve for High Dose Rate Image-Guided Brachytherapy in Cervix Cancer. Conference. Feasibility of CT/MRI Compatible Cervix Sleeve for High Dose Rate Image-Guided Brachytherapy in Cervix Cancer. San Diego, CA, US.
- 2007. Imaging in the Treatment of Breast Cancer. Conference. 1199 Educational Symposium. New York, NY, US.
- 2006. IOral Presentation, ICRU Reference Points Underestimate Rectal and Bladder Doses as Compared to CT Planned Dose-Volume Histograms in Interstitial HDR Brachytherapy of Locally Advanced Cervix Carcinoma. Conference. IOral Presentation, ICRU Reference Points Underestimate Rectal and Bladder Doses as Compared to CT Planned Dose-Volume Histograms in Interstitial HDR Brachytherapy of Locally Advanced Cervix Carcinoma. Philadelphia, PA, US.
- 2006. Image-Guided Tandem and Colpostate High Dose Rate Brachytherapy for Cervical Cancer. Conference. Image-Guided Tandem and Colpostate High Dose Rate Brachytherapy for Cervical Cancer. Philadelphia, PA, US.
- 2006. ICRU Points Significantly Underestmates the Bladder and Rectal Dose Delivereed by HDR Brachytherapy for Cervical Cancer. Conference. ICRU Points Significantly Underestmates the Bladder and Rectal Dose Delivereed by HDR Brachytherapy for Cervical Cancer. Philadelphia, PA, US.
- 2005. Targeting the Tie-2 Receptor Tyrosine Kinase Pathway for Radiosensitization of Prostate Cancer. Conference. Targeting the Tie-2 Receptor Tyrosine Kinase Pathway for Radiosensitization of Prostate Cancer. Denver, CO, US.
- 2005. Oral Presentation,Cytotoxicity and Radiosensitization in Cervical Carcinoma Cells by ON 01910, A Novel Polo-Like Kinase 1 Inhibitor. Conference. Oral Presentation,Cytotoxicity and Radiosensitization in Cervical Carcinoma Cells by ON 01910, A Novel Polo-Like Kinase 1 Inhibitor. Denver, CO, US.
- 2005. ON01910, A Novel benzyl styrl sulfone is a promising radiosensitizer with a good therapeutic ratio. Conference. ON01910, A Novel benzyl styrl sulfone is a promising radiosensitizer with a good therapeutic ratio. San Francisco, CA, US.
- 2005. Interstitial Brachytherapy for the Perioperative Treatment of Soft Tissue Sarcoma with Positive or Close Margins. Conference. Interstitial Brachytherapy for the Perioperative Treatment of Soft Tissue Sarcoma with Positive or Close Margins. San Francisco, CA, US.
- 2002. Radiation Induced Liver Damage (RILD) in a Cirrhotic Rat Model. Conference. Radiation Induced Liver Damage (RILD) in a Cirrhotic Rat Model. New Orleans, LA, US.
- 2001. Flt-3-Ligand in Combination with CD40 Ligand Gene Transfer Improves Survival in Mice with Diffuse Hepatocellular Carcinoma. Conference. Flt-3-Ligand in Combination with CD40 Ligand Gene Transfer Improves Survival in Mice with Diffuse Hepatocellular Carcinoma. Dallas, TX, US.
- 2001. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. Conference. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. San Francisco, CA, US.
- 2001. Oral Presentation, A Novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. Conference. Oral Presentation, A Novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. San Francisco, CA, US.
- 2001. Selective Hepatic Lobar Repopulation by Transplanted Hepatocytes After Ligation of a Portal Vein Branch and Preparative Irradiation. Conference. Selective Hepatic Lobar Repopulation by Transplanted Hepatocytes After Ligation of a Portal Vein Branch and Preparative Irradiation. Dallas, TX, US.
International Presentations
- 2023. Adaptive Therapy in Head and Neck Cancer. Invited. SBRT - Brazil Radiation Therapy Society. rio de janeiro, BR.
- 2019. Proton Therapy in Head and Neck Malignancies. Invited. Proton Therapy in Head and Neck Malignancies. Ahmedabad, IN.
- 2007. Technique for Customized Parametrial Boost Fields for Locally Advanced Cervical Carcinoma using Nucletron Plato & Varian Varis Planning Systems. Conference. Technique for Customized Parametrial Boost Fields for Locally Advanced Cervical Carcinoma using Nucletron Plato & Varian Varis Planning Systems. Rome, IT.
Formal Peers
- 2010. Multidisciplinary Management of Head and Neck Cancer. Invited. Multidisciplinary Management of Head and Neck Cancer, Patna, Bihar, US.
- 2010. Escalation to De-escalation? The Emerging Role of Treatment for HPV Positive Disease. Invited. Escalation to De-escalation? The Emerging Role of Treatment for HPV Positive Disease, Patna, Bihar, US.
- 2009. Post Residency Fellowships. Invited. Post Residency Fellowships. Chicago, IL, US.
- 2007. Hepatocellular Carcinoma. Invited. Hepatocellular Carcinoma. Galveston, TX, US.
- 2007. The Treatment of Prostate and Breast Cancer. Invited. The Treatment of Prostate and Breast Cancer. New York, NY, US.
- 2007. Imaging in the Treatment of Breast Cancer. Invited. Imaging in the Treatment of Breast Cancer. New York, NY, US.
- 2006. Stereotactic Radiosurgery. Invited. Stereotactic Radiosurgery. Bronx, NY, US.
- 2005. Cervical Cancer. Invited. Cervical Cancer. Bronx, NY, US.
- 2005. Pancreatic Cancer. Invited. Pancreatic Cancer. Bronx, NY, US.
- 2004. Management of Rectal Carcinoma. Invited. Management of Rectal Carcinoma. Bronx, NY, US.
Grant & Contract Support
| Title: | Road to Wellness Program |
| Funding Source: | United 4 a Cure |
| Role: | Principal Investigator-MDACC |
| Title: | Dietary Correlates of IGF-1 |
| Funding Source: | United 4 a Cure |
| Role: | Principal Investigator-MDACC |
Patient Reviews
CV information above last modified March 25, 2025